Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age
Clinical trial NCT05193279 · WITHDRAWN
Trial details
- NCT number
- NCT05193279
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2022-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.